Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Baxter Ventures VP Anne Sissel Says Strategic Investors Can Help Start-Ups Reach Their Potential

April 4, 2018

Anne Sissel, vice president of ventures at Baxter International, followed her love of numbers into Medtech. But she quickly came to appreciate just how powerful an impact start-up innovation can have on treating the sick. Now she’s working on behalf of Baxter Ventures to find young companies that need capital and guidance. Sissel will lead a panel about the strategic-start-up relationship at the upcoming Medtech Conference on May 31.

Anne Sissel

VP, Ventures

Baxter International

Anne Sissel is the Vice President and Head of Baxter Ventures. Baxter Ventures is the corporate venture capital fund of Baxter International, investing in companies with innovative technologies, products and/or therapies. Prior to Baxter, Anne was on the executive team for Veracyte, Inc. leading the finance and business development organization from early discovery through commercialization. Prior to Veracyte, Anne worked in the Investment Banking Division of Goldman, Sachs & Co. in New York and San Francisco. Anne has completed over $200bn in financing and M&A transactions for clients in the healthcare industry. Anne holds an MBA from the Wharton School of the University of Pennsylvania and a BS in Finance from Indiana University. She was selected to Crain’s Chicago Business Top 40 Under 40 in 2016. Anne’s current Board and Observation roles representing Baxter include: Kit Check, Medasense, TVA Medical and VitalConnect.